Cipla gets DCGI nod to import Moderna vaccine for emergency use in India

[bhaigan]

India’s drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna’s Covid-19 vaccine for restricted emergency use in the country.

“New drug permission has been granted to Moderna, the first internationally developed vaccine. This new drug permission is for restricted use,” Dr VK Paul, who heads the Covid Task Force in the country confirmed.

Moderna’s vaccine will be the fourth Covid-19 jab to be available in India after Covishield, Covaxin and Sputnik.

India recorded 37,566 new covid-19 cases in the 24 hours ending 8 am Tuesday, taking the country’s total to 3.03 crore. This is the lowest single-day spike since March 17 and less than 40,000 daily cases after 102 days. Out of these, active cases fell to 5.52 lakh while over 2.93 crore people have recovered. With 907 new deaths, the toll is now at 3.97 lakh. Not a single state has reported more than 10,000 cases. Top contributor Kerala had 8,063 cases, while Maharashtra reported 6,727.